HEALTH

GelStat hires direct marketing agency to spearhead marketing efforts behind GelStat Migraine, Sleep

BY Michael Johnsen

PALM CITY, Fla. — GelStat Corporation on Monday announced that it has retained List Services Corp. to manage all branding and marketing efforts for GelStat Corporation and its products, GelStat Migraine and GelStat Sleep. LSC is a direct marketing agency that has evolved from a list management and brokerage house into a full service solution.

"LSC and its team have a long-term proven track record of building and supporting leading brands [with] insight on how the convergence of big data and technology is affecting … marketing efforts and sales channels," stated Gerald Kieft, GelStat CEO. "Now that we have the right marketing team in place, I’m confident that we have the platform necessary to drive revenue and build shareholder value."

LSC, as its marketing partner, will act as GelStat’s in-sourced marketing services group to build its brand of healthcare products and drive demand for those products through a number of communications and media channels. The effort will be led by LSC chief strategic officer Charlie Tarzian acting as GelStat’s chief marketing officer.

Services provided by LSC will include strategic brand and communications channel planning, media planning and buying, media trafficking, creative services, data modeling and analytics, campaign management, reporting and reconciliation.

LSC will deploy a hybrid model that will include a small, retained group of senior marketing professionals that will be responsible for the day-to-day running and managing of the business; and a project-based, as-needed staff of marketing specialists that will be called upon across the various stages of the relationship to perform specific tasks and functions. 


Find us on Facebook for more insight, analysis and the latest in drug store news.

keyboard_arrow_downCOMMENTS

Leave a Reply

m.dawson says:
Aug-18-2013 01:42 am

There are also offset printing service that you can use together with direct mail marketing, if these idea where applied in proper marketing techniques, then it will have better result.

TRENDING STORIES

HEALTH

JAMA report criticizing calcium supplementation in men raises eyebrows among supplement associations

BY Michael Johnsen

CHICAGO — A JAMA report released Monday afternoon that suggested a high intake of supplemental calcium is associated with an increased risk of cardiovascular disease death in men was criticized by several dietary supplement agencies for being inconclusive. According to the Council for Responsible Nutrition’s most recent survey of U.S. adults, 17% indicated they take a calcium supplement.

"This study has the same unfortunate design defects as previous studies yielding mixed results," stated Taylor Wallace, senior director, scientific and regulatory affairs, CRN. "The National Institutes of Health–AARP Diet & Health Study was originally designed by researchers at the National Cancer Institute to look specifically at epidemiologic investigations of diet and cancer, not to measure cardiovascular or cerebrovascular outcomes," he said. "The science behind the safety and benefit of calcium supplementation is well-established; and this study proves inconsistent with a recent wave of new research that concludes that calcium supplementation is beneficial to bone health, and also poses no risk to cardiovascular health."

"While this study includes a large population and a long follow-up time, it also has weaknesses in that it doesn’t capture all the pertinent information regarding duration of calcium supplementation or other nutrients," commented Cara Welch, SVP scientific and regulatory affairs Natural Products Association. "The Natural Products Association does not believe that this study should cause anyone to stop taking their calcium supplements. We have long recommended that you should discuss your calcium intake with your healthcare professional.”

Taylor noted that dietary supplement usage has increased dramatically over the course of time encompassed by the study and subsequent follow-up. "This includes calcium supplement usage which has increased among men in the past two decades as dairy consumption has decreased and the incidence of osteoporosis among this population has become increasingly evident," he said. "The results of this study are most likely confounded by the lack of data collected during the 11-year follow up because the number of baseline nonusers who became users of calcium supplements was likely to have increased substantially."

The study consisted of more than 388,000 participants from the National Institutes of Health–AARP Diet & Health Study between the ages of 50 and 71 years, according to a report published online first by JAMA Internal Medicine, a JAMA Network publication. During an average 12 years of follow-up, researchers noted that 7,904 cardiovascular disease deaths in men and 3,874 cardiovascular disease deaths in women were identified and supplements containing calcium were used by 51% of men and 70% of women, respectively. “In this large, prospective study we found that supplemental but not dietary calcium intake was associated with an increased CVD mortality in men but not in women,” the authors concluded. For women, supplemental calcium intake was not associated with CVD death, heart disease death or cerebrovascular disease death. Dietary calcium intake also was not associated with CVD death in men or women.

“Whether there is a sex difference in the cardiovascular effect of calcium supplement warrants further investigation. Given the extensive use of calcium supplement in the population, it is of great importance to assess the effect of supplemental calcium use beyond bone health,” the authors concluded.


Find us on Facebook for more insight, analysis and the latest in drug store news.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Merz North America names VP Merz Aesthetics unit, moves OTC under Aesthetics umbrella

BY Michael Johnsen

GREENSBORO, N.C. — Merz North America on Monday named Jim Hartman VP of the Merz Aesthetics business unit, which includes Xeomin, Radiesse and Belotero Balance. 

Hartman was hired in June 2012 to lead the U.S. Dermatology Business Unit, which includes Naftin, Mederma and the recently launched Onmel. Prior to joining Merz, Hartman was VP global marketing and business development at Obagi Medical Products, a provider of topical skin care treatments. 

As part of the move, the U.S. OTC business that includes Mederma will continue to report into Hartman under the direction Jessica Wright, associate director of OTC franchise, and will move to the Aesthetics Business Unit. Wright joined Merz in June 2001 as associate brand manager. Throughout the 11 years that she has been with the company, she has held several roles within marketing, marketing communications and brand management for the company’s OTC franchise. Prior to Merz, Wright worked as a medical editor with Sandler & Recht Communications. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES